Patents by Inventor Kaisa Naelapää

Kaisa Naelapää has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20230000949
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: January 5, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge, Kaisa Naelapaeae
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220395559
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist, an SLGT2 inhibitor, a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, and a hydrotrope. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 15, 2022
    Inventors: Kaisa Naelapaeae, Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220323544
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: August 7, 2020
    Publication date: October 13, 2022
    Inventors: Betty Lomstein Pedersen, Birgitte Nissen, Kaisa Naelapaeae, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220265777
    Abstract: The invention relates to solid pharmaceutical compositions comprising a GLP-1 agonist, an SGLT2 inhibitor and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: August 6, 2020
    Publication date: August 25, 2022
    Inventors: Betty Lomstein Pedersen, Birgitte Nissen, Patrick William Garibay, Kaisa Naelapaeae, Andreas Vegge
  • COATED TABLETS WITH REMAINING DEGRADATION SURFACE OVER THE TIME
    Publication number: 20110142905
    Abstract: The present invention relates to a pharmaceutical composition for controlled delivery of at least one active ingredient into an aqueous phase, said pharmaceutical composition comprising: a tablet, preferably obtainable by compression, said tablet comprising said at least one active ingredient and optionally excipients; and a coating, applied on said tablet, said coating covering at least part of said tablet to impede the release of said at least one active ingredient from at least part of the surface of said tablet, said coating being applied in a manner allowing the release of said at least one active ingredient from said tablet after contacting said pharmaceutical composition with said aqueous phase, establishing one or more degradation surfaces of said tablet; wherein the first derivative of the area of each degradation surface with respect to time is larger than or equal to zero.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 16, 2011
    Applicant: BIONEER A/S
    Inventors: Daniel Bar-Shalom, Kaisa Naelapää